FDA Plans Offices In China As Heparin Case Unfolds, With India On Deck
This article was originally published in The Tan Sheet
Executive Summary
FDA is moving rapidly to establish offices in Asia, with firm plans developing in China, and India next in line
You may also be interested in...
FDA kicks off “new era” in China
Health and Human Services Secretary Mike Leavitt opens FDA offices in China at the U.S. Embassy in Beijing, the U.S. Consulate General in Guangzhou and the U.S. consular mission in Shanghai, HHS says Nov. 18. "We're opening up a new era, not just new offices," Leavitt says, adding that eight senior agency officials in China will "ensure that quality and safety are built into food and consumer products at the point of manufacture." The U.S.-China partnership stems from a 2007 memorandum of agreement (1"The Tan Sheet" March 24, 2008, p. 16). HHS says FDA will have a presence in the Middle East, India, Europe and Latin America
FDA kicks off “new era” in China
Health and Human Services Secretary Mike Leavitt opens FDA offices in China at the U.S. Embassy in Beijing, the U.S. Consulate General in Guangzhou and the U.S. consular mission in Shanghai, HHS says Nov. 18. "We're opening up a new era, not just new offices," Leavitt says, adding that eight senior agency officials in China will "ensure that quality and safety are built into food and consumer products at the point of manufacture." The U.S.-China partnership stems from a 2007 memorandum of agreement (1"The Tan Sheet" March 24, 2008, p. 16). HHS says FDA will have a presence in the Middle East, India, Europe and Latin America
FDA kicks off “new era” in China
Health and Human Services Secretary Mike Leavitt opens FDA offices in China at the U.S. Embassy in Beijing, the U.S. Consulate General in Guangzhou and the U.S. consular mission in Shanghai, HHS says Nov. 18. "We're opening up a new era, not just new offices," Leavitt says, adding that eight senior agency officials in China will "ensure that quality and safety are built into food and consumer products at the point of manufacture." The U.S.-China partnership stems from a 2007 memorandum of agreement (1"The Tan Sheet" March 24, 2008, p. 16). HHS says FDA will have a presence in the Middle East, India, Europe and Latin America